Current price is more than the intrinsic value

Intrinsic Value

ROE vs FD rates

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Procter & Gamble Health Ltd registered volume of 44265 shares by 14:12 IST on NSE, a 10.65 fold spurt over two-week average daily volume of 4157 shares

Volumes spurt at Procter & Gamble Health Ltd counter

Procter & Gamble Health Ltd notched up volume of 45597 shares by 10:48 IST on BSE, a 8.05 fold spurt over two-week average daily volume of 5667 shares

Procter & Gamble Health reported a net profit of Rs 51.16 crore in Q3 March 2022, up by 224.41% as compared with Q3 March 2022.

Procter & Gamble Health records PAT of Rs 51 crore in Q3

Procter & Gamble Health standalone net profit rises 224.41% in the March 2022 quarter

Adani Power, Adani Transmission, Dabur India, Marico, Exide Industries, TVS Motor Company, Voltas, Computer Age Management Services, CEAT, Firstsource Solutions, Intellect Design Arena, Procter & Gamble Health, PNB Gilts, are among the companies scheduled to release earnings today

Stocks to Watch: SBI, Kotak Mahindra Bank, Dabur, Marico, Adani Power

EPL Ltd, Kolte Patil Developers Ltd, Procter & Gamble Health Ltd and Welspun India Ltd are among the other losers in the BSE’s ‘A’ group today, 11 March 2022.

Future Retail Ltd leads losers in ‘A’ group

The company had reported a profit after tax (PAT) of Rs 68 crore in the October-December period of the last year.

Procter & Gamble Health profit falls by 34% to Rs 45 crore in October-December

Madhavan has around 37 years of experience in Accountancy, Economics, Finance and many other fields.

Procter & Gamble Health appoints Subramanian Madhavan as Non-Executive Independent Director

On a standalone basis, Procter & Gamble (P&G) Health company’s net profit fell 6.6% to Rs 55.37 crore on a 3.3% rise in net sales to Rs 272.80 crore in Q1 September 2021 over Q1 September 2020.

Procter & Gamble Health Q1 FY22 PAT slips 7% to Rs 55 cr

Dr. Elizabeth Desmond’s appointment as an Additional Director (Non-Executive) is effective from September 24, 2021.

Dr Elizabeth Desmond takes charge as Director on resignation of Sujay Wasan at Procter & Gamble Health

Procter & Gamble Health Q4 net profit declines 30.63% to Rs 33.89 cr

Procter & Gamble Health Limited, formerly Merck Limited, is engaged in manufacturing and marketing of pharmaceuticals, bulk drugs, fine chemicals and pigments

Procter & Gamble Health Ltd

Procter & Gamble Health Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Volumes spurt at Procter & Gamble Health Ltd counter

Volumes spurt at Procter & Gamble Health Ltd counter

Procter & Gamble Health records PAT of Rs 51 crore in Q3

Procter & Gamble Health standalone net profit rises 224.41% in the March 2022 quarter

Stocks to Watch: SBI, Kotak Mahindra Bank, Dabur, Marico, Adani Power

Future Retail Ltd leads losers in ‘A’ group

Procter & Gamble Health profit falls by 34% to Rs 45 crore in October-December

Procter & Gamble Health Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Volumes spurt at Procter & Gamble Health Ltd counter

Volumes spurt at Procter & Gamble Health Ltd counter

Procter & Gamble Health records PAT of Rs 51 crore in Q3

Procter & Gamble Health standalone net profit rises 224.41% in the March 2022 quarter

Stocks to Watch: SBI, Kotak Mahindra Bank, Dabur, Marico, Adani Power

Future Retail Ltd leads losers in ‘A’ group

Procter & Gamble Health profit falls by 34% to Rs 45 crore in October-December

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock